The Shadow That Tells a Story
Imagine looking in the mirror and seeing a shadow beneath your eyes that whispers a story of exhaustion, even when you have slept well. This is one of the most common concerns that brings patients into the clinic, especially as they enter their forties and fifties. The shadow under the eye is not just a cosmetic issue; it is a complex interplay of anatomy, aging, and light. Last week, I treated a patient who felt that tiredness when she saw her reflection. The challenge was to decide whether that shadow could be softened with a dermal filler, or whether something else entirely was needed.
Two Types of Shadows, Two Different Paths
Not all dark circles are the same. In fact, I believe there are two distinct types of tear troughs: primary and secondary. A primary tear trough is something you can see in children—my own children have them. These are shadows that have always been there, often triggering patients to seek treatment in their early twenties or thirties. The tricky part for clinicians is that these primary tear troughs are the hardest to improve. The shadow is caused by a strongly attached tear trough ligament, not by volume loss. So when a patient says, "I've had this my whole life," it is a red flag that filler may not be the answer.
Secondary tear troughs, on the other hand, develop as the face ages. The fat pads shift and volume decreases, creating a shadow that was never there before. This type of shadow is more responsive to treatment because we are correcting an imbalance in the fat pads. By restoring volume, we can blend the shadow and catch the light differently. The ideal patient is someone who never had a shadow but now notices one forming. A simple test with a cotton bud can help: if you push gently under the ligament and the skin elevates outward, that is a good sign that filler can lift the area and reduce the shadow.
Why So Many Clinicians Fear This Area
There is good reason for caution. The tear trough area has the highest rate of reversal among all facial aesthetic procedures. Many clinicians say it is not worth the risk—and in some hands, for some patients, that may be true. But with the right knowledge and technique, the risk can be mitigated. The most common side effect is not blindness, as many fear, but simply visible filler. A patient may come in for a shadow, and after treatment, they end up with a bulge, a lump, or a bluish tint (the Tyndall effect) that becomes a new distraction. In my own audit of clinicians with less than two years of experience, this happened about five percent of the time—the highest rate of reversal of any procedure I have seen. The skin under the eye is only 0.2 millimeters thick. There is no room for error.
To reduce the risk, we must choose the right patients, the right product, and the right technique. Let me break down the key pitfalls and how to avoid them.
Patient Selection: Saying No Is a Skill
The first line of defense is knowing who not to treat. A primary tear trough in a young person is often a poor candidate. Also, ask about periorbital edema—if a patient wakes up puffy every morning, that is a clue that they will be even puffier after filler. These patients are at high risk for persistent swelling. Sometimes the best recommendation is surgery, not filler. You must be willing to say no.
Product Choice: The Foundation of Safety
You cannot use just any product in this area. Standard fillers attract water and cause edema. Early in my career, I did not have access to the newer products, and my reversal rate was higher. I was so afraid of failure that I injected tiny amounts, which actually made me a better injector—but it was a struggle. Now, I use products like Juvederm Volbella or Restylane 2. These are low-moisture-attracting, malleable, and stay where they are placed. I am not a representative of Allergan; this is simply my experience. Volbella has been available since 2013-2014, and I have found it causes significantly less periorbital edema than older products like Juvederm Ultra 2. The key is that the product does not swell after injection, so the result you see at the table is the result you get.
Technique: The Art of Precise Placement
Even with the best product, technique matters. The most important principle is to inject deep—on the periosteum, the bone surface. I prefer a needle for this because it allows me to place a small bolus exactly where I want it. A cannula, by contrast, tends to bounce off resistant tissue and ends up in an intermediate depth, which is more superficial and more likely to cause lumps or puffiness. I do use a cannula in certain patients, but for the medial tear trough, a needle gives me control.
Before injecting, I always check that I am on the periosteum and not pointing toward the orbit. Many beginners mistake the shadow where the lower lid meets the cheek for the tear trough, but that is actually just above the orbital rim. If you inject there, you can go straight through the orbital membrane and into the orbit. That is a catastrophe. So always palpate with a cotton bud or your finger to confirm you are on a flat, hard surface.
I use a BD syringe to quantify the exact amount—0.05 ml per bolus. This prevents overfilling, which is the most common mistake. New injectors often use a cannula and get heavy-handed, injecting too much volume. With a BD syringe, you can only inject the amount you have drawn up. I also aspirate before injecting, and I watch the tissue rise as I inject. If the product goes where it should, the tissue elevates smoothly. If it goes into a vessel, the tissue will not rise in the same way. This visual feedback is a powerful safety signal.
Holistic Thinking: The Cheek and the Tear Trough
The tear trough does not exist in isolation. It is affected by volume in the cheek, both laterally and medially. If you only fill the medial third of the tear trough, you will create an unnatural look—a hollow lateral orbital junction and a bulging medial area. Always think holistically. Address the cheek first, then the lateral aspect of the tear trough, and only then the medial shadow. This approach reduces the amount of filler needed in the delicate area and creates a more harmonious result.
A Final Reflection
Reducing dark circles is not about chasing a shadow with a needle. It is about understanding the story behind the shadow: Is it primary or secondary? Is the patient a good candidate? What product and technique will minimize risk? Every patient is different, and the wise clinician knows when to proceed and when to step back. The tear trough is a place of no mistakes—but with the right knowledge, it can be a place of profound transformation.